INTEGRATED BIOPHARMA REPORTS SECOND QUARTER RESULTS
Integrated BioPharma, Inc. INB reported financial results today for the three
and six month periods ended December 31, 2005. Net income applicable to common
shareholders for the quarter was $685,518, or $0.05 per diluted share, compared
with a net loss of $3.3 million, or $(0.26) per diluted share, for the same
period in 2004.